MANZF yields 3544.84% · MRK yields 2.76%● Live data
📍 MANZF pulled ahead of the other in Year 1
Combined, MANZF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MANZF + MRK for your $10,000?
Manz AG engages in the manufacture and sale of high-tech equipment in Germany, the United States, Taiwan, rest of Europe, China, and internationally. The company operates in five segments: Solar, Electronics, Energy Storage, Contract Manufacturing, and Service. The Solar segment provides system solutions for thin-film solar modules and CIGS thin-film technology. The Electronics segment offers production, assembly, and handling systems for the manufacture of flat screen displays, touch sensors, printed circuit boards, chip carriers, smartphones, tablet computers, laptops, wearables, and other consumer electronics; and automated assembly solutions for the automotive industry. The Energy Storage segment offers production, assembly, and handling equipment for lithium-ion battery cells, modules, and systems, as well as for capacitors for the manufacture of consumer electronics, power electronics, and other components of electrical powertrain. The Contract Manufacturing segment provides contract manufacturing services for equipment manufacturing, parts production, and assembly works for range of industries. The Service segment offers after-sales services, such as repair and maintenance, or conversion and upgrade services for machines and assemblies. Manz AG also provides simulation and factory planning, process and prototype development, and customer training services. The company was formerly known as Manz Automation AG and changed its name to Manz AG in June 2011. Manz AG was founded in 1987 and is based in Reutlingen, Germany.
Full MANZF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.